Protective role of gap junctions in preconditioning against myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Miura, Tetsuji ^a   Ohnuma, Yoshito ^a   Kuno, Atsushi ^a   Tanno, Masaya ^a   Ichikawa, Yoshihiko ^a   Nakamura, Yuichi ^a   Yano, Toshiyuki ^a   Miki, Takayuki ^a   Sakamoto, Jun ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Connexin43; Infarct size; Lucifer yellow

Indexed keywords

CALPHOSTIN C; CONNEXIN 43; DIACETYL OXIME; GLYCYRRHETINIC ACID; HEPTANOL; LUCIFER YELLOW; PROTEIN KINASE C INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; GAP JUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RABBIT; WESTERN BLOTTING;

EID: 9144257246     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00441.2003     Document Type: Article

References (50)

1. Armstrong SC, Kao R, Gao W, Schivell LC, Downey JM, Honkanen RE, and Ganote CE. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effects of a protein phosphatase inhibitor, fostriecin. J Mol Cell Cardiol 29: 3009-3024, 1997.
2. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kleber AG, Schuessler RB, and Saffitz JE. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 87: 656-662, 2000.
3. ATP channel. Annu Rev Physiol 62: 79-109, 2000.
4. Daleau P, Boudriau S, Michaud M, Jolicoeur C, and Kingma JG. Preconditioning in the absence or presence of sustained ischemia modulates myocardial Cx43 protein levels and gap junction distribution. Can J Physiol Pharmacol 79: 371-378, 2001.
5. Davidson JS and Baumgarten IM. Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J Pharmacol Exp Ther 246:1104-1107, 1988.
6. Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol Sci 19: 229-241, 1998.
7. Doble BW, Ping P, and Kardami E. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phorphorylation. Circ Res 86: 293-301, 2000.
8. + entry. J Mol Cell Cardiol 30: 829-835, 1998.
9. Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Soleres J, Julia M, Barrabes JA, and Soler-Soler J. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96: 3579-3586, 1997.
10. Garcia-Dorado D, Ruiz-Meana M, Padilla F, Rodriguez-Sinovas A, and Mirabet M. Gap junction-mediated intracellular communication in ischemic preconditioning. Cardiovasc Res 55: 456-465, 2002.
11. Guan X, Wilson S, Schlender KK, and Ruch RJ. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18β-glycyrrhetinic acid. Mol Carcinog 16: 157-164, 1996.
12. Gysembergh A, Kloner RA, and Przyklenk K. Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart. Cardiovasc Pathol 10; 13-17, 2001.
13. Jain SK, Schuessler RB, and Saffitz JE. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 92: 1138-1144, 2003.
14. Jennings RB, Murry CE, and Reimer KA. Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J Mol Cell Cardiol 23: 1449-1458, 1991.
15. Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, and Kardami E. Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol Cell Biochem 242: 129-134, 2003.
16. Kondo RP, Wang SY, John SA, Weiss JN, and Goldhaber JI. Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J Mol Cell Cardiol 32: 1859-1872, 2000.
17. Krieg T, Qin Q, McIntosh EC, Cohen MV, and Downey JM. ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol Heart Circ Physiol 283: H2322-H2330, 2002.
18. Kwak BR and Jongsma HJ. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol Cell Biochem 157: 93-99, 1996.
19. Kwak BR, van Veen TA, Analbers LJ, and Jongsma HJ. TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp Cell Res 220: 456-463, 1995.
20. Lampe PD and Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 384: 205-215, 2000.
21. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, and Lau AF. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junction communication. J Cell Biol 149: 1503-1512, 2000.
22. i in rabbit ventricular myocytes during metabolic inhibition. J Mol Cell Cardiol 33: 2145-2155, 2001.
23. Li G, Whittaker P, Yao M, Kloner RA, and Przyklenk K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol 11: 158-165, 2002.
24. Li W and Nagy JI. Connexin43 phosphorylation state and intercellular communication in cultured astrocytes following hypoxia and protein phosphatase inhibition. Eur J Neurosci 12: 2644-2650, 2000.
25. ATP channel. Am J Physiol Heart Circ Physiol 273: H847-H853, 1997.
26. Liu GS, Cohen MV, Mochly-Rosen D, and Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31: 1937-1948, 1999.
27. Liu Y, Sato T, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection? Circulation 97: 2467-2469, 1998.
28. Miki T, Miura T, Tanno M, Sakamoto J, Kuno A, Genda S, Matsumoto T, Ichikawa Y, and Shimamoto K. Postinfarct ventricular remodeling impairs the mechanism of ischemic preconditioning at the level of PKC-ε activation. Mol Cell Biochem 247: 185-193, 2003.
29. 1 receptor activation. J Am Coll Cardiol 35: 238-245, 2000.
30. + exchange inhibitor, Hoe642: difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol 29: 693-701, 1997.
31. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
32. Murry CE, Richard VJ, Reimer KA, and Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931, 1990.
33. Nozawa Y, Miura T, Miki T, Ohnuma Y, Yano T, and Shimamoto K. Mitochondrial KATP channel-dependent and -independent phases of ischemic preconditioning against myocardial infarction in the rat. Basic Res Cardiol 98: 50-58, 2003.
34. ATP channel occurs down-stream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol 283: H440-H447, 2002.
35. ATP channels triggers the preconditioning state by generating free radicals, Circ Res 87: 460-466, 2000.
36. + exchange. Am J Physiol Heart Circ Physiol 265: H2017-H2026, 1993.
37. Piper M, Garcia-Dorado D, and Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 38: 291-300, 1998.
38. + through gap junctions. Circ Res 85: 280-287, 1999.
39. Ruiz-Meana M, Garcia-Dorado D, Lane S, Pina P, Inserte J, Mirabet M, and Soler-Soler J. Persistence of gap junction communication during myocardial ischemia. Am J Physiol Heart Circ Physiol 280: H2563-H2571, 2001.
40. + channels by protein kinase C. Circ Res 83: 110-114, 1998.
41. Schlack W, Uebing A, Schäfer M, Bier F, Schäfer S, Piper HM, and Thämer V. Regional contractile blockade at the onset of reperfusion reduces infarct size in the dog heart. Pflügers Arch 428: 134-141, 1994.
42. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, and Heusch G. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 283: H1740-H1742, 2002.
43. Schulz R, Cohen MV, Behrends M, Downey JM, and Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res 52: 181-198, 2001.
44. Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, and Heusch G. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 17: 1355-7, 2003.
45. Sebbag L, Verbinski SG, Reimer KA, and Jennings RB. Protection of ischemic myocardium in dogs using intracoronary 2,3-butanedione monoxime (BDM). J Mol Cell Cardiol 35: 165-176, 2003.
46. Tan HL, Mazon P, Verberne HJ, Sleeswijk ME, Coronel R, Opthof T, and Janse MJ. Ischaemic preconditioning delays ischaemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. Cardiovasc Res 27: 644-651, 1993.
47. ATP channels, and protein kinase C. J Am Coll Cardiol 40: 1523-1530, 2002.
48. Verrecchia F and Herve JC. Reversible blockade of gap junctional communication by 2,3-butanedione monoxime in rat cardiac myocytes. Am J Physiol Cell Physiol 272: C875-C885, 1997.
49. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol 280: H246-H256, 2001.
50. Zhao L, Naber N, and Cooke R. Muscle cross-bridges bound to actin are disordered in the presence of 2,3-butanedione monoxime. Biophys J 68: 1980-1990, 1995.